GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigen Biotechnology Corp (ROCO:3176) » Definitions » Cyclically Adjusted Book per Share

Medigen Biotechnology (ROCO:3176) Cyclically Adjusted Book per Share : NT$16.78 (As of Mar. 2025)


View and export this data going back to 2011. Start your Free Trial

What is Medigen Biotechnology Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Medigen Biotechnology's adjusted book value per share for the three months ended in Mar. 2025 was NT$12.105. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$16.78 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Medigen Biotechnology's average Cyclically Adjusted Book Growth Rate was -6.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -0.60% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 2.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Medigen Biotechnology was 6.00% per year. The lowest was -0.60% per year. And the median was 5.05% per year.

As of today (2025-06-29), Medigen Biotechnology's current stock price is NT$30.70. Medigen Biotechnology's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was NT$16.78. Medigen Biotechnology's Cyclically Adjusted PB Ratio of today is 1.83.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Medigen Biotechnology was 6.38. The lowest was 1.57. And the median was 2.97.


Medigen Biotechnology Cyclically Adjusted Book per Share Historical Data

The historical data trend for Medigen Biotechnology's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medigen Biotechnology Cyclically Adjusted Book per Share Chart

Medigen Biotechnology Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.49 17.24 18.60 18.22 16.93

Medigen Biotechnology Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.03 17.68 17.33 16.93 16.78

Competitive Comparison of Medigen Biotechnology's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Medigen Biotechnology's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medigen Biotechnology's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medigen Biotechnology's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Medigen Biotechnology's Cyclically Adjusted PB Ratio falls into.


;
;

Medigen Biotechnology Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medigen Biotechnology's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=12.105/134.9266*134.9266
=12.105

Current CPI (Mar. 2025) = 134.9266.

Medigen Biotechnology Quarterly Data

Book Value per Share CPI Adj_Book
201506 19.272 100.684 25.826
201509 18.772 100.392 25.230
201512 17.984 99.792 24.316
201603 18.289 100.470 24.561
201606 17.271 101.688 22.916
201609 16.647 101.861 22.051
201612 15.873 101.863 21.025
201703 15.095 102.862 19.800
201706 14.451 103.349 18.866
201709 14.328 104.136 18.565
201712 13.249 104.011 17.187
201803 12.949 105.290 16.594
201806 13.186 106.317 16.734
201809 12.472 106.507 15.800
201812 11.084 105.998 14.109
201903 10.902 107.251 13.715
201906 11.430 108.070 14.271
201909 10.798 108.329 13.449
201912 9.793 108.420 12.187
202003 9.819 108.902 12.166
202006 9.705 108.767 12.039
202009 10.349 109.815 12.716
202012 13.062 109.897 16.037
202103 13.595 111.754 16.414
202106 14.084 114.631 16.578
202109 15.420 115.734 17.977
202112 17.181 117.630 19.707
202203 17.775 121.301 19.772
202206 18.106 125.017 19.541
202209 18.239 125.227 19.652
202212 15.734 125.222 16.953
202303 14.133 127.348 14.974
202306 13.634 128.729 14.290
202309 13.377 129.860 13.899
202312 11.422 129.419 11.908
202403 11.174 131.776 11.441
202406 12.029 132.554 12.244
202409 12.059 133.029 12.231
202412 11.355 133.157 11.506
202503 12.105 134.927 12.105

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Medigen Biotechnology  (ROCO:3176) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Medigen Biotechnology's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=30.70/16.78
=1.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Medigen Biotechnology was 6.38. The lowest was 1.57. And the median was 2.97.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Medigen Biotechnology Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Medigen Biotechnology's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Medigen Biotechnology Business Description

Traded in Other Exchanges
N/A
Address
Yuancyu Street, 14F, Building No.3,, Nangang District, Taipei, TWN, 11560
Medigen Biotechnology Corp is a biopharmaceutical company engaged in new drug development, drug discovery, molecular diagnostics, vaccine, and generic drugs. The company has four segments: Nucleic acid department: segment, which derives maximum revenue, is responsible for services of testing reagents, instruments and inspection on behalf of others; New drug and vaccine research and development segment: responsible for the development and relevant services of new drugs and vaccine; Cytotherapy department: responsible for research and development and relevant services of cytotherapy; and Generic drug, aesthetic medicine product and dietary supplement segment is responsible for production and sales and relevant services of western medicine, aesthetic medicine product and dietary supplement.

Medigen Biotechnology Headlines

No Headlines